Tempus stock price — NASDAQ TEM overview

Tempus stock price

The term tempus stock price refers to the market quote for Tempus AI, Inc. (ticker: TEM) as traded on the NASDAQ. This page explains how the Tempus stock price is reported (real‑time vs delayed), what drives its movements, key market metrics and financial data to watch, notable events and catalysts that have affected TEM, and practical guidance on where and how to follow or trade the security. Readers will learn which filings and data points are most relevant, how to interpret short interest and analyst coverage, and how corporate events such as option exercises or large contracts can influence the Tempus stock price.

Overview

The phrase tempus stock price denotes the market valuation signal for Tempus AI, Inc. Investors and observers follow the Tempus stock price because the company operates at the intersection of artificial intelligence and healthcare — a sector that attracts growth capital, analyst attention and regulatory scrutiny. Movements in the Tempus stock price reflect both company‑specific updates (earnings, partnerships, product launches) and broad market forces (sector rotation, interest rates, macro risk appetite).

About Tempus AI, Inc.

Tempus AI, Inc. is a technology‑driven healthcare company focusing on genomics, clinical data aggregation and AI applications designed to improve clinical decision making and accelerate research. The company collects molecular and clinical data, develops analytic models and sells diagnostic, data and software tools to healthcare providers, researchers and life sciences companies.

• Headquarters: United States (headquarters city varies by public filings).
• Founding: Founded by entrepreneurs with backgrounds in technology and healthcare data.
• Leadership: The company’s leadership team includes the founder/CEO and senior executives overseeing research, commercialization and operations; check the company's investor relations for up‑to‑date officer names and bios.

Corporate history and milestones

Key events that tend to affect the tempus stock price include the company’s IPO and listing, major collaborations with health systems or pharmaceutical partners, commercial rollouts of diagnostics or software, significant financing rounds, and material regulatory communications. Milestones such as large contract awards, new product approvals, or partnerships with research institutions or biopharma firms can create visible shifts in sentiment and trading activity for TEM.

Stock basics

Ticker and exchange

Tempus AI trades under the ticker TEM on the NASDAQ. Regular trading hours for NASDAQ are typically 09:30–16:00 Eastern Time, with pre‑market and after‑hours sessions available through many brokers. Pre‑market and after‑hours activity is often reported separately and can show different prices than regular session quotes because liquidity and participant composition differ.

IPO information

Tempus completed its public listing in mid‑2024. The initial public offering set a reference price and created the publicly traded float that determines the ongoing tempus stock price. IPO details — including offering date, initial share price and underwriting context — are available in the company’s IPO prospectus and SEC filings.

Price data and charts

Real‑time vs. delayed quotes

Understanding the difference between real‑time and delayed quotes is fundamental when monitoring the tempus stock price:

• Real‑time quotes: Supplied by exchange feeds and paid data vendors; show the most recent trade price and best bid/ask at or near the current second. Real‑time feeds are what active traders rely on but may require subscription access through brokers, platforms or professional terminals.
• Delayed quotes: Commonly shown as a 15‑minute or longer delay on many public websites and free portals. These are useful for general awareness but can differ materially from the immediate market level during volatile periods.
• Why delays occur: Data licensing, vendor costs and website configurations cause many free sources to present delayed data rather than real‑time feeds.

Intraday price movement

Intraday reporting for the tempus stock price typically includes open, high, low and close prices for the trading session, traded volume, bid/ask quotes and real‑time charts. Common intraday chart tools allow traders to view minute‑by‑minute price action, volume spikes, and short‑term technical indicators. When assessing intraday moves:

• Watch the opening price relative to the prior close for immediate sentiment clues.
• Note high/low ranges for volatility; wide intraday ranges often reflect news or low liquidity.
• Volume spikes often signal institutional activity, news reactions or block trades that can meaningfully change the Tempus stock price.

Historical performance

Historical charts for the tempus stock price are examined across standard horizons — 1‑day, 1‑week, 1‑month, 6‑month, year‑to‑date (YTD), 1‑year and multi‑year periods. Analysts and investors use various chart types:

• Candlestick charts: Show open/high/low/close per period and are favored by traders for visualizing session structure.
• Line charts: Useful for a cleaner long‑term visual of price direction.
• Moving averages: Simple and exponential moving averages (e.g., 50‑day, 200‑day) provide trend context that many market participants reference when evaluating the Tempus stock price.

Key market metrics

Key market metrics provide context for the tempus stock price. When reading quotes, make sure each numeric figure is dated because market cap, volume and ratios change continuously.

• Market capitalization: The aggregate market value of all outstanding shares; date the figure when quoting.
• Shares outstanding & float: Total issued shares vs the number available for public trading (float). Changes from secondary offerings or large option exercises can affect float and price dynamics.
• Average daily volume: A liquidity metric used to gauge how easily positions can be entered or exited; report it with a specified time window (e.g., 30‑day average) and date.
• 52‑week high/low: Provides a simple range for recent extremes in the Tempus stock price.
• Dividend: Tempus is a growth‑oriented technology and healthcare data company; as of the latest filings it does not pay a cash dividend — confirm via the company’s investor relations for up‑to‑date data.
• Valuation ratios: Price/Earnings (P/E), Price/Sales (P/S), Price/Book (P/B) and enterprise multiples (EV/EBITDA). For early‑stage or fast‑growing companies the P/E may be negative; always check the accounting period and date.

Common valuation and financial metrics affecting price

Common valuation metrics that influence perceptions of the tempus stock price include:

• P/E ratio: Useful when the company is profitable. If earnings are negative, P/E is not meaningful.
• Price/Sales: Often used for growth companies where earnings are negative; it measures the market value relative to revenue.
• Gross and net margins: Margin improvement can support higher price multiples.
• EBITDA and cash flow: Operating profitability and cash generation matter to long‑term valuation.
• Balance sheet strength: Cash on hand, debt levels and other liquidity metrics affect resilience to downturns and thus influence the Tempus stock price.

Note: Single ratios should not be used in isolation to explain price movements; combine multiple metrics and trend analysis.

Notable price events and catalysts

Events that have historically produced notable changes in the tempus stock price include:

• Earnings releases: Quarterly results that exceed or miss guidance can cause immediate price reactions.
• Large contracts and partnerships: Announcements of multi‑year deals with health systems or pharma firms can shift investor expectations for revenue growth.
• Regulatory or reimbursement updates: Changes in reimbursement policy or regulatory determinations around diagnostics can materially affect future revenue potential.
• Product launches: Commercial rollouts of diagnostics, companion tests or AI‑powered clinical tools.
• Corporate actions: Secondary offerings, share repurchases, option exercises or insider transactions that alter share count or signal management views.
• Macro and sector trends: Healthcare funding cycles, biotech sector rotations and broader risk‑on/risk‑off moves in equity markets.

Example: As of January 16, 2026, Benzinga reported that a disclosed option exercise added 5,000 Tempus shares (exercise of call options with a strike price of $20), an item market watchers noted as a small but visible insider‑related flow; the same Benzinga report showed the Tempus stock price trading in a range near the high‑$60s intraday on that date. These types of disclosures are routinely included in public government and insider transaction reports and may be referenced by market participants when assessing short‑term trading interest.

Financial performance and guidance

Revenue growth, margins, guidance and cash position strongly influence the tempus stock price. Investors watch quarterly earnings, management guidance and the company’s discussion of trends in key end markets (oncology, genomics, clinical trials). When management provides forward revenue or margin guidance, the market re‑prices expectations; conversely, guidance reductions often produce downward pressure on the Tempus stock price.

To evaluate financial drivers, consult the company’s Form 10‑Q and Form 10‑K filings and quarterly earnings scripts. These filings contain revenue breakdowns by product line, margins, R&D spend, and cash runway — each of which provides context for valuation and the Tempus stock price.

Ownership and trading interest

Insider ownership and institutional holders

Insider ownership (founders, executives and board members) and institutional holdings (mutual funds, pension funds, asset managers) affect liquidity and sentiment toward the tempus stock price. High insider ownership can align management incentives with shareholders; large institutional positions can both stabilize trading and create concentrated flows when funds rebalance. For the most recent ownership breakdown consult the company’s proxy statement (DEF 14A) and institutional holdings reports available through major market data portals and the company’s investor relations materials.

Short interest and options activity

Short interest is a valuable indicator of market positioning and potential volatility for the tempus stock price. Short interest is measured as the number of shares sold short and often expressed as a percentage of float and as “days to cover” (short interest divided by average daily volume). Higher short interest can mean greater downward pressure if fundamentals worsen — but it also increases the potential for sharp short‑covering rallies if positive news appears.

As of January 2026, according to Benzinga reporting, Tempus AI had approximately 20.07 million shares sold short, representing about 15.64% of the publicly available float, and an estimated 5.11 days to cover. Short interest levels change each reporting period, so always check dated short interest reports when referencing this metric.

Options market activity (put/call volume, open interest and implied volatility) can also signal where traders expect the tempus stock price to move. Elevated options volume around earnings, regulatory decisions or product launches often precedes larger intraday moves.

Analyst coverage and price targets

Sell‑side analysts publish research notes with consensus ratings (buy/hold/sell) and price targets that can influence sentiment around the tempus stock price. Analyst revisions — up or down — are driven by changes to revenue forecasts, margin assumptions, competitive positioning and key partnerships. Remember that analyst targets vary across firms and represent individual forecasts, not guarantees.

To gauge the market view, review consensus figures that aggregate multiple analyst price targets and note the date of each revision. Check the company’s investor relations materials and major financial portals for rolling updates to analyst coverage.

Risks and factors influencing TEM share price

Risks that commonly influence the tempus stock price include:

• Execution risk: The company’s ability to commercialize products at scale and convert partnerships into recurring revenue.
• Regulatory & reimbursement risk: Decisions that affect whether or how payors will reimburse tests or services can materially change revenue visibility.
• Concentration risk: Dependence on a small number of large customers or partners can amplify revenue volatility.
• Competition: Rapid innovation from established diagnostics firms, health‑tech startups or large incumbents could pressure market share.
• Financial leverage & cash flow: The need for additional capital or dilution through secondary offerings can influence the Tempus stock price.
• Macro risks: Interest rate changes, sector rotations and broad equity market stress can depress valuations even when company fundamentals remain stable.

All of the above factors should be considered with dated evidence from filings, press releases and third‑party research; this page is informational and not investment advice.

How to track and trade TEM

Practical steps to follow the tempus stock price and trade the security:

• Official filings: Read the company’s SEC filings (10‑Q, 10‑K, 8‑K) and investor presentations for authoritative financial details and dated disclosures.
• Market data portals: Use major financial information sites for quotes and charts — examples include Yahoo Finance, Google Finance, Morningstar, Finviz, CNBC and other reputable data providers.
• Broker platforms: Many retail brokers provide streaming quotes, order entry and extended hours trading. When choosing an execution venue, consider fees, order types and the availability of real‑time market data. For crypto‑native or Web3 asset access, use the Bitget platform for spot and derivatives trading; for custody and Web3 wallet needs, consider the Bitget Wallet.
• Order types: Market orders execute at the best available price and may suffer from slippage in volatile periods; limit orders let you specify a maximum (buy) or minimum (sell) price. For extended hours trading, the liquidity profile differs so pay attention to bid/ask spreads.
• Pre‑market/after‑hours quotes: These sessions can move the expected open price. Use caution when interpreting extended hours prices since lower liquidity tends to widen spreads and increase potential price swings in the Tempus stock price.

Before trading, review the company’s latest earnings release and listen to earnings calls for management commentary on growth drivers and risks that may influence the Tempus stock price.

Historical timeline (select chronology)

• Founding and early growth: The company built an early dataset and platform combining genomics and clinical data to support AI research in healthcare.
• Strategic partnerships: Announcements of collaborations with research institutions or pharmaceutical companies signaled commercial adoption and were reflected in subsequent price moves.
• IPO (mid‑2024): The public offering established TEM as a NASDAQ‑listed equity and provided a benchmark price; post‑IPO trading was influenced by growth expectations and sector sentiment.
• Product rollouts and regulatory updates: Commercial availability of tests or AI tools, as well as regulatory determinations, affected investor expectations and the Tempus stock price.
• Insider and institutional flows (2025–2026): Periodic disclosures of option exercises, insider sales or institutional buys — including reported option exercises that added shares in January 2026 — have been tracked by market participants as part of supply/demand dynamics for TEM.

See also

• Healthcare AI and genomics public companies
• Biotech and diagnostics sector ETFs
• Market metrics: short interest, float, market capitalization

References

Primary sources used to compile this page (no external links provided here):

• Tempus AI investor relations materials and SEC filings (investor relations, EDGAR filings)
• Benzinga market news and insider transaction reporting (reported January 2026)
• Major financial data providers and portals: Yahoo Finance, Google Finance, Morningstar, Finviz, CNBC, CNN
• Exchange reported short interest and market data feeds as published on market data portals

External links

Suggested pages to consult for live quotes and official documents (search these names directly):

• Tempus AI — Investor Relations
• SEC EDGAR — Tempus AI filings
• Major finance portals for live quotes and charts (Yahoo Finance, Google Finance, Morningstar, Finviz, CNBC)

Notes on usage and currency

Market data such as price, market capitalization, volume and valuation ratios are time‑sensitive. Any numeric figures quoted on this page should be read with their report date. For example, as of January 16, 2026, Benzinga reported intraday Tempus stock price prints in the high‑$60s and a short interest report showing ~20.07 million shares sold short (~15.64% of float) with ~5.11 days to cover. For live price lookups and up‑to‑date metrics consult exchange feeds, the company’s investor relations materials and the data portals listed above.

Practical closing guidance

If you want to monitor or act on the tempus stock price, start with the company’s latest SEC filings and investor presentations for documented financials and guidance. Use reputable market data portals for quotes and charts, and execute trades through a licensed broker platform that provides real‑time data if you require immediate market access. For crypto or Web3 integrations and wallet needs, consider Bitget Wallet and Bitget’s trading services for related digital asset workflows.

Further exploration: to dig deeper into what moves the tempus stock price, follow dated earnings reports, short interest updates and material press announcements. Stay aware of sector trends and regulatory developments in healthcare diagnostics and AI, and always verify the date on any numeric metric you reference.

To explore more tools and data that can help you follow TEM and other healthcare‑AI equities, check the investor relations page maintained by Tempus and the market data portals named above for live charting, historical performance and analyst coverage summaries.